April 17, 2025 a 07:31 am
RMD: Fundamental Ratio Analysis - ResMed Inc.
ResMed Inc. has been a reliable player in the healthcare industry, leveraging technology to offer innovative solutions. With strong fundamentals, the company maintains its place in the medical devices and software markets, providing significant value to investors.
Fundamental Rating
Overall, ResMed Inc. has a solid fundamental rating of B+. This reflects the company's commendable performance across various financial metrics.
| Category | Score (out of 5) | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Historical Rating
The current scores mirror steady performance over the recent period, indicating consistent results.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-04-16 | 3 | 4 | 5 | 5 | 2 | 2 | 1 |
| Previous | 0 | 4 | 5 | 5 | 2 | 2 | 1 |
Analyst Price Targets
Market analysts have set a positive outlook on ResMed Inc.'s stock with median price targets suggesting potential appreciation.
| High | Low | Median | Consensus |
|---|---|---|---|
| $260 | $240 | $250 | $250 |
Analyst Sentiment
The stock has garnered significant interest from analysts, with the majority recommending a 'Buy'.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 15 | |
| Hold | 12 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
ResMed Inc. stands out strongly in its sector with robust financial health and a promising outlook. Though it faces potential risks from debt levels, its consistent performance and market position offer substantial upside potential. Investors are likely to find value given current analyst sentiments and projected price targets. Continuous innovation and market strategy are key to maintaining its growth trajectory.